Abbott reports strong Q1 but pulls guidance

Apr. 16, 2020 7:49 AM ETAbbott Laboratories (ABT)ABTBy: Mamta Mayani, SA News Editor17 Comments
  • Abbott Laboratories (ABT) Q1 results:
  • Revenues: $7,726M (+2.5%); Nutrition: $1,904M (+6.3%); Diagnostics: $1,826M (-0.8%); Established Pharmaceuticals: $1,044M (+5.2%); Medical Devices: $2,937M (+1.4%).
  • Net Income: $564M (-16.1%); EPS: $0.30 (-21.1%); non-GAAP Net Income: $1,162M (+3.2%); non-GAAP EPS: $0.65 (+3.2%).
  • Abbott is suspending its previously announced annual guidance for 2020, due to uncertainties regarding the impact of COVID-19 pandemic.
  • Shares are up 1% premarket.
  • Previously: Abbott Laboratories EPS beats by $0.04, beats on revenue (April 16)

Recommended For You

Comments (17)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.